HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its Chief Executive Officer, Dr. Juan Vera, will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, being held in a virtual format on February 25-26, 2026. Presentation Details: Event:Oppenheime ...

Following the Addition of General Jack Keane, REalloys Further Strengthens Board with Addition of Former Vice Chairman of UBS Investment Bank Blackboxstocks/REalloys Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close the merger DALLAS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackboxstocks” or the “Company”) today announced that its merger target, REalloys Inc. (“REalloys”), has entered into a designate director ...

CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in The Citizens Life Sciences Conference on Wednesday, March 11, 2026, in Miami, FL. Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt Hill, the Company’s Chief Financial Officer, will participate i ...

Expands patent protection across major global pharmaceutical markets, including the U.S., China and Asia-Pacific Enables scalable, automated manufacturing of diverse immune cell therapies using proprietary 3D expansion technology Strengthens positioning in China’s growing cell therapy market and supports cross-border partnerships HAIFA, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (“Pluri”, the “Company”, “we”, “our” or “us”) (Nasdaq and TASE: PLUR ), a leading biotechnology company leveraging its ...

Adds three new denture base shades (DP, LP, RP) to better match diverse natural gum tones and address real patient diversityExpands production flexibility for dental laboratoriesReinforces market leadership in monolithic, multi-material denture printingDelivers up to 300% faster production, over 50% less manual labor, and one-day turnaround (vs. five days traditional) — slashing labor, streamlining workflows, and cutting costs for labs ROCK HILL, S.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Today, 3D Systems (NY ...

Leadership Transition - GPGI, Inc. announced the departure of Husky Technologies' CEO Bradley Selleck and CFO John Linker, effective April and March 2026 respectively, for personal reasons [1][2] - Active searches for their replacements are underway, with no expected disruptions to the company's strategic priorities or operations during this transition [2] Company Outlook - Mr. Selleck emphasized Husky's strong position in a favorable industry and the growth opportunities presented by GPGI's ownership, highlighting the potential for profitable growth [3] - Mr. Linker noted GPGI's financial strength and commitment to innovation as key factors for Husky's continued success [3] - GPGI's Executive Chairman David Cote expressed confidence in the ongoing leadership search and the implementation of the Resolute Operating System to support Husky's growth [3] Company Profile - GPGI, Inc. is a diversified platform managed by Resolute Holdings, focused on acquiring and scaling high-quality businesses [4] - Husky, founded in 1953, is a leader in highly engineered equipment and aftermarket services, providing solutions for manufacturing a variety of plastic products [5]

Core Viewpoint - Vaxart, Inc. is set to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, highlighting its focus on developing oral vaccines using a proprietary delivery platform [1][2]. Company Overview - Vaxart is a clinical-stage biotechnology company specializing in oral recombinant vaccines that can be stored and shipped without refrigeration, thus eliminating needle-stick injury risks [3]. - The company is developing vaccines targeting coronavirus, norovirus, influenza, and a therapeutic vaccine for human papillomavirus (HPV), marking its entry into immune-oncology [3]. - Vaxart has filed extensive domestic and international patent applications for its oral vaccination technology, which utilizes adenovirus and TLR3 agonists [3]. Presentation Details - The presentation is scheduled for February 25, 2026, at 4:00 PM ET, and will be available for 30 days on the company's investor relations website [2]. - Vaxart will also engage in one-on-one meetings during the conference for interested investors [2].

WALTHAM, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced scientific presentations at the 21st Congress of the European Crohn’s and Colitis Organisation (ECCO), held February 18-21, 2026 in Stockholm, Sweden. “We are excited to share follow-up data out to 20 weeks fro ...

Patent Covers Generation of Multiple Audience-Adaptive Commentary Video Variants While Preserving Factual IntegrityFREEHOLD, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that its subsidiary, Avalon Quantum AI LLC, has filed a new U.S. provisional patent application covering an artificial intelligenc ...

Core Viewpoint - Sezzle has launched Sezzle Mobile, an all-in-one mobile plan offering unlimited 5G data on AT&T's network starting at $29.99 per month, aimed at enhancing user experience by integrating mobile connectivity into its financial platform [1][4]. Group 1: Product Offering - Sezzle Mobile provides a straightforward mobile phone plan with transparent pricing, starting at $29.99 per month, significantly lower than the average U.S. single-line mobile plan which costs between $70-100 [4]. - The plan includes unlimited talk and text, unlimited HD streaming, and roaming in Canada and Mexico, with instant eSIM activation available in the app [9]. Group 2: Integration and User Experience - The new mobile plan is fully integrated into the Sezzle app, allowing users to manage their mobile service alongside shopping and financial tools, simplifying the user experience [5][6]. - Users can cancel the plan at any time without incurring cancellation fees, emphasizing the simplicity and flexibility of the service [5]. Group 3: Strategic Expansion - Sezzle Mobile represents a strategic expansion of Sezzle's ecosystem, moving beyond payment solutions to include essential services like mobile connectivity, thereby reducing financial stress for users [2][6]. - The integration of mobile services aligns with Sezzle's mission to empower consumers by providing a comprehensive financial hub that includes payments, subscriptions, and discounts on everyday essentials [6][7].